Publications

Intravenous administration of an engineered AAV9-gene-silencing vector suppresses human SOD1 and extends survival in an ALS mouse model

 69
Intravenous administration of an engineered AAV9-gene-silencing vector suppresses human SOD1 and extends survival in an ALS mouse model

Tags:

Previous Article

How muscle cells grow and stay healthy

Next Article

MicroRNA-based gene therapy to treat ALS 

Related Posts

High-resolution functional mapping of RAD51C by saturation genome editing

High-resolution functional mapping of RAD51C by saturat...

 128

A light-induced microprotein triggers regulated intramembrane proteolysis to promote photo-sensing in a pathogenic bacterium

A light-induced microprotein triggers regulated intrame...

 86

Point-of-care GlycoStrips detect serum and salivary antibodies to blood group antigens and pathogens

Point-of-care GlycoStrips detect serum and salivary ant...

 55